{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:05:24Z","timestamp":1758603924959,"version":"3.44.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Undergraduate Education Teaching Reform Research and Practice Program","award":["GJXY202418"],"award-info":[{"award-number":["GJXY202418"]}]},{"name":"The Basic Research Program of Key Science and Technology Research Projects in Henan Province","award":["24A180008"],"award-info":[{"award-number":["24A180008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11030-024-11072-8","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T01:26:39Z","timestamp":1733534799000},"page":"4645-4662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design"],"prefix":"10.1007","volume":"29","author":[{"given":"Yunpeng","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny Danilo","family":"Belviso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"issue":"7","key":"11072_CR1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/hmg\/7.7.1071","volume":"7","author":"I Stec","year":"1998","unstructured":"Stec I, Wright TJ, van Ommen GJ et al (1998) WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet 7(7):1071\u20131082. https:\/\/doi.org\/10.1093\/hmg\/7.7.1071","journal-title":"Hum Mol Genet"},{"issue":"2","key":"11072_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2007-05-088674","volume":"111","author":"J Lauring","year":"2008","unstructured":"Lauring J, Abukhdeir AM, Konishi H et al (2008) The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood 111(2):856\u2013864. https:\/\/doi.org\/10.1182\/blood-2007-05-088674","journal-title":"Blood"},{"key":"11072_CR3","doi-asserted-by":"publisher","unstructured":"Sarai N, Nimura K, Tamura T et al (2013) WHSC1 links transcription elongation to HIRA-mediated histone H33 deposition. EMBO J 32(17):2392\u20132406. https:\/\/doi.org\/10.1038\/emboj.2013.176","DOI":"10.1038\/emboj.2013.176"},{"issue":"7846","key":"11072_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-03069-8","volume":"590","author":"W Li","year":"2021","unstructured":"Li W, Tian W, Yuan G et al (2021) Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases. Nature 590(7846):498\u2013503. https:\/\/doi.org\/10.1038\/s41586-020-03069-8","journal-title":"Nature"},{"issue":"7332","key":"11072_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature09658","volume":"470","author":"H Pei","year":"2011","unstructured":"Pei H, Zhang L, Luo K et al (2011) MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 470(7332):124\u2013128. https:\/\/doi.org\/10.1038\/nature09658","journal-title":"Nature"},{"issue":"2","key":"11072_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4049\/jimmunol.1201811","volume":"190","author":"H Pei","year":"2013","unstructured":"Pei H, Wu X, Liu T, Yu K, Jelinek DF, Lou Z (2013) The histone methyltransferase MMSET regulates class switch recombination. J Immunol 190(2):756\u2013763. https:\/\/doi.org\/10.4049\/jimmunol.1201811","journal-title":"J Immunol"},{"issue":"6","key":"11072_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00018-022-04321-2","volume":"79","author":"I Topchu","year":"2022","unstructured":"Topchu I, Pangeni RP, Bychkov I et al (2022) The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. Cell Mol Life Sci 79(6):285. https:\/\/doi.org\/10.1007\/s00018-022-04321-2","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"11072_CR8","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-10-1302","volume":"17","author":"HR Hudlebusch","year":"2011","unstructured":"Hudlebusch HR, Santoni-Rugiu E, Simon R et al (2011) The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 17(9):2919\u20132933. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1302","journal-title":"Clin Cancer Res"},{"issue":"12","key":"11072_CR9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.febslet.2009.05.038","volume":"583","author":"HB Kang","year":"2009","unstructured":"Kang HB, Choi Y, Lee JM et al (2009) The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription. FEBS Lett 583(12):1880\u20131886. https:\/\/doi.org\/10.1016\/j.febslet.2009.05.038","journal-title":"FEBS Lett"},{"issue":"1","key":"11072_CR10","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1038\/s41467-018-07511-4","volume":"9","author":"A Aytes","year":"2018","unstructured":"Aytes A, Giacobbe A, Mitrofanova A et al (2018) NSD2 is a conserved driver of metastatic prostate cancer progression. Nat Commun 9(1):5201. https:\/\/doi.org\/10.1038\/s41467-018-07511-4","journal-title":"Nat Commun"},{"issue":"1","key":"11072_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41420-021-00402-6","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhu L, Guo M et al (2021) Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2. Cell Death Discov 7(1):19. https:\/\/doi.org\/10.1038\/s41420-021-00402-6","journal-title":"Cell Death Discov"},{"issue":"2","key":"11072_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/1541-7786.MCR-14-0292-T","volume":"13","author":"V Saloura","year":"2015","unstructured":"Saloura V, Cho HS, Kiyotani K et al (2015) WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol Cancer Res 13(2):293\u2013304. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0292-T","journal-title":"Mol Cancer Res"},{"issue":"8","key":"11072_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41401-018-0199-z","volume":"40","author":"JJ Wang","year":"2019","unstructured":"Wang JJ, Zou JX, Wang H et al (2019) Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling. Acta Pharmacol Sin 40(8):1067\u20131075. https:\/\/doi.org\/10.1038\/s41401-018-0199-z","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"11072_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.molcel.2011.08.042","volume":"44","author":"AJ Kuo","year":"2011","unstructured":"Kuo AJ, Cheung P, Chen K et al (2011) NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell 44(4):609\u2013620. https:\/\/doi.org\/10.1016\/j.molcel.2011.08.042","journal-title":"Mol Cell"},{"issue":"1","key":"11072_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.molcel.2012.10.008","volume":"49","author":"IA Asangani","year":"2013","unstructured":"Asangani IA, Ateeq B, Cao Q et al (2013) Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. Mol Cell 49(1):80\u201393. https:\/\/doi.org\/10.1016\/j.molcel.2012.10.008","journal-title":"Mol Cell"},{"issue":"9","key":"11072_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004566","volume":"10","author":"R Popovic","year":"2014","unstructured":"Popovic R, Martinez-Garcia E, Giannopoulou EG et al (2014) Histone methyltransferase MMSET\/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet 10(9):e1004566. https:\/\/doi.org\/10.1371\/journal.pgen.1004566","journal-title":"PLoS Genet"},{"key":"11072_CR17","doi-asserted-by":"publisher","unstructured":"Yu JR, LeRoy G, Bready D et al (2021) The H3K36me2 writer-reader dependency in H3K27M-DIPG. Sci Adv 7(29):eabg7444. https:\/\/doi.org\/10.1126\/sciadv.abg7444","DOI":"10.1126\/sciadv.abg7444"},{"issue":"6","key":"11072_CR18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1177\/1087057114525854","volume":"19","author":"A Allali-Hassani","year":"2014","unstructured":"Allali-Hassani A, Kuznetsova E, Hajian T et al (2014) A basic post-SET extension of NSDs is essential for nucleosome binding in vitro. J Biomol Screen 19(6):928\u2013935. https:\/\/doi.org\/10.1177\/1087057114525854","journal-title":"J Biomol Screen"},{"issue":"21","key":"11072_CR19","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1021\/jacs.6b01612","volume":"138","author":"MB Poulin","year":"2016","unstructured":"Poulin MB, Schneck JL, Matico RE et al (2016) Nucleosome binding alters the substrate bonding environment of histone H3 lysine 36 methyltransferase NSD2. J Am Chem Soc 138(21):6699\u20136702. https:\/\/doi.org\/10.1021\/jacs.6b01612","journal-title":"J Am Chem Soc"},{"issue":"5","key":"11072_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1073\/pnas.1521036113","volume":"113","author":"MB Poulin","year":"2016","unstructured":"Poulin MB, Schneck JL, Matico RE et al (2016) Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36. Proc Natl Acad Sci U S A 113(5):1197\u20131201. https:\/\/doi.org\/10.1073\/pnas.1521036113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"11072_CR21","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/ajmg.a.40498","volume":"176","author":"NJ Boczek","year":"2018","unstructured":"Boczek NJ, Lahner CA, Nguyen TM et al (2018) Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2). Am J Med Genet A 176(12):2798\u20132802. https:\/\/doi.org\/10.1002\/ajmg.a.40498","journal-title":"Am J Med Genet A"},{"issue":"8","key":"11072_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41436-021-01158-1","volume":"23","author":"P Zanoni","year":"2021","unstructured":"Zanoni P, Steindl K, Sengupta D et al (2021) Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype. Genet Med 23(8):1474\u20131483. https:\/\/doi.org\/10.1038\/s41436-021-01158-1","journal-title":"Genet Med"},{"issue":"11","key":"11072_CR23","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ng.2777","volume":"45","author":"JD Jaffe","year":"2013","unstructured":"Jaffe JD, Wang Y, Chan HM et al (2013) Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Genet 45(11):1386\u20131391. https:\/\/doi.org\/10.1038\/ng.2777","journal-title":"Nat Genet"},{"issue":"1","key":"11072_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/leu.2013.204","volume":"28","author":"JA Oyer","year":"2014","unstructured":"Oyer JA, Huang X, Zheng Y et al (2014) Point mutation E1099K in MMSET\/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies. Leukemia 28(1):198\u2013201. https:\/\/doi.org\/10.1038\/leu.2013.204","journal-title":"Leukemia"},{"issue":"5","key":"11072_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41388-018-0474-y","volume":"38","author":"A Swaroop","year":"2019","unstructured":"Swaroop A, Oyer JA, Will CM et al (2019) An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia. Oncogene 38(5):671\u2013686. https:\/\/doi.org\/10.1038\/s41388-018-0474-y","journal-title":"Oncogene"},{"issue":"1","key":"11072_CR26","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1038\/s41467-021-26913-5","volume":"12","author":"K Sato","year":"2021","unstructured":"Sato K, Kumar A, Hamada K et al (2021) Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2. Nat Commun 12(1):6605. https:\/\/doi.org\/10.1038\/s41467-021-26913-5","journal-title":"Nat Commun"},{"issue":"35","key":"11072_CR27","doi-asserted-by":"publisher","first-page":"13750","DOI":"10.1074\/jbc.RA118.004274","volume":"293","author":"NP Coussens","year":"2018","unstructured":"Coussens NP, Kales SC, Henderson MJ et al (2018) High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2. J Biol Chem 293(35):13750\u201313765. https:\/\/doi.org\/10.1074\/jbc.RA118.004274","journal-title":"J Biol Chem"},{"issue":"12","key":"11072_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41589-020-0626-6","volume":"16","author":"H Huang","year":"2020","unstructured":"Huang H, Howard CA, Zari S et al (2020) Covalent inhibition of NSD1 histone methyltransferase. Nat Chem Biol 16(12):1403\u20131410. https:\/\/doi.org\/10.1038\/s41589-020-0626-6","journal-title":"Nat Chem Biol"},{"key":"11072_CR29","doi-asserted-by":"publisher","unstructured":"Fang D, Gan H, Lee JH et al (2016) The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science 352(6291):1344\u20131348. https:\/\/doi.org\/10.1126\/science.aae0065","DOI":"10.1126\/science.aae0065"},{"issue":"1","key":"11072_CR30","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/s41467-018-04127-6","volume":"9","author":"L Zhuang","year":"2018","unstructured":"Zhuang L, Jang Y, Park YK et al (2018) Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function. Nat Commun 9(1):1796. https:\/\/doi.org\/10.1038\/s41467-018-04127-6","journal-title":"Nat Commun"},{"key":"11072_CR31","doi-asserted-by":"publisher","unstructured":"Rajagopalan KN, Chen X, Weinberg DN et al (2021) Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation. Proc Natl Acad Sci USA 118(9):e2021795118. https:\/\/doi.org\/10.1073\/pnas.2021795118","DOI":"10.1073\/pnas.2021795118"},{"issue":"5","key":"11072_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197082","volume":"13","author":"MJ Morrison","year":"2018","unstructured":"Morrison MJ, Boriack-Sjodin PA, Swinger KK et al (2018) Identification of a peptide inhibitor for the histone methyltransferase WHSC1. PLoS ONE 13(5):e0197082. https:\/\/doi.org\/10.1371\/journal.pone.0197082","journal-title":"PLoS ONE"},{"issue":"11","key":"11072_CR33","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1021\/acschembio.6b00308","volume":"11","author":"D Tisi","year":"2016","unstructured":"Tisi D, Chiarparin E, Tamanini E et al (2016) Structure of the epigenetic oncogene MMSET and inhibition by N-alkyl sinefungin derivatives. ACS Chem Biol 11(11):3093\u20133105. https:\/\/doi.org\/10.1021\/acschembio.6b00308","journal-title":"ACS Chem Biol"},{"issue":"1","key":"11072_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbrc.2018.11.037","volume":"508","author":"Y Shen","year":"2019","unstructured":"Shen Y, Morishita M, Lee D et al (2019) Identification of LEM-14 inhibitor of the oncoprotein NSD2. Biochem Biophys Res Commun 508(1):102\u2013108. https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.037","journal-title":"Biochem Biophys Res Commun"},{"key":"11072_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113592","volume":"222","author":"S Wang","year":"2021","unstructured":"Wang S, Yang H, Su M et al (2021) 5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma. Eur J Med Chem 222:113592. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113592","journal-title":"Eur J Med Chem"},{"issue":"16","key":"11072_CR36","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.1021\/acs.jmedchem.3c00948","volume":"66","author":"Z Ma","year":"2023","unstructured":"Ma Z, Bolinger AA, Chen H, Zhou J (2023) Drug discovery targeting nuclear receptor binding SET domain protein 2 (NSD2). J Med Chem 66(16):10991\u201311026. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00948","journal-title":"J Med Chem"},{"key":"11072_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.108965","volume":"317","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zheng J, Zou JX et al (2020) S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis. Chem Biol Interact 317:108965. https:\/\/doi.org\/10.1016\/j.cbi.2020.108965","journal-title":"Chem Biol Interact"},{"key":"11072_CR38","doi-asserted-by":"publisher","unstructured":"Larkin MA, Blackshields G, Brown NP et al (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21):2947\u20132948. https:\/\/doi.org\/10.1093\/bioinformatics\/btm404","DOI":"10.1093\/bioinformatics\/btm404"},{"key":"11072_CR39","doi-asserted-by":"publisher","unstructured":"Webb B, Sali A (2016) Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics 54:5.6.1\u20135.6.37. https:\/\/doi.org\/10.1002\/cpbi.3","DOI":"10.1002\/cpbi.3"},{"issue":"1","key":"11072_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/prot.22879","volume":"79","author":"S Ramachandran","year":"2011","unstructured":"Ramachandran S, Kota P, Ding F, Dokholyan NV (2011) Automated minimization of steric clashes in protein structures. Proteins 79(1):261\u2013270. https:\/\/doi.org\/10.1002\/prot.22879","journal-title":"Proteins"},{"issue":"Pt 4","key":"11072_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66(Pt 4):486\u2013501. https:\/\/doi.org\/10.1107\/S0907444910007493","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"W1","key":"11072_CR42","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkv495","volume":"43","author":"H Lee","year":"2015","unstructured":"Lee H, Heo L, Lee MS, Seok C (2015) GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Res 43(W1):W431\u2013W435. https:\/\/doi.org\/10.1093\/nar\/gkv495","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"11072_CR43","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2013ligand discovery for everyone. J Chem Inf Model 55(11):2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"issue":"11\u201312","key":"11072_CR44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang SY (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15(11\u201312):444\u2013450. https:\/\/doi.org\/10.1016\/j.drudis.2010.03.013","journal-title":"Drug Discov Today"},{"issue":"1","key":"11072_CR45","doi-asserted-by":"publisher","first-page":"2289355","DOI":"10.1080\/14756366.2023.2289355","volume":"39","author":"X Jin","year":"2024","unstructured":"Jin X, Wang Y, Chen J et al (2024) Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations. J Enzyme Inhib Med Chem 39(1):2289355. https:\/\/doi.org\/10.1080\/14756366.2023.2289355","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"17","key":"11072_CR46","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.3390\/molecules24173181","volume":"24","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Di B, Niu MM (2019) Structure-based pharmacophore design and virtual screening for novel tubulin inhibitors with potential anticancer activity. Molecules 24(17):3181. https:\/\/doi.org\/10.3390\/molecules24173181","journal-title":"Molecules"},{"issue":"14","key":"11072_CR47","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"11072_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jtice.2014.11.028","volume":"49","author":"M Niu","year":"2015","unstructured":"Niu M, Wang F, Li F, Dong Y, Gu Y (2015) Establishment of a screening protocol for identification of aminopeptidase N inhibitors. J Taiwan Inst Chem Eng 49:19\u201326. https:\/\/doi.org\/10.1016\/j.jtice.2014.11.028","journal-title":"J Taiwan Inst Chem Eng"},{"key":"11072_CR49","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"W1","key":"11072_CR50","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46(W1):W257\u2013W263. https:\/\/doi.org\/10.1093\/nar\/gky318","journal-title":"Nucleic Acids Res"},{"key":"11072_CR51","doi-asserted-by":"publisher","unstructured":"Xiong G, Wu Z, Yi J et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(W1):W5\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkab255","DOI":"10.1093\/nar\/gkab255"},{"key":"11072_CR52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3389\/fphar.2017.00889","volume":"8","author":"P Schyman","year":"2017","unstructured":"Schyman P, Liu R, Desai V, Wallqvist A (2017) vNN web server for ADMET predictions. Front Pharmacol 8:889. https:\/\/doi.org\/10.3389\/fphar.2017.00889","journal-title":"Front Pharmacol"},{"issue":"22","key":"11072_CR53","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","volume":"33","author":"D Lagorce","year":"2017","unstructured":"Lagorce D, Bouslama L, Becot J, Miteva MA, Villoutreix BO (2017) FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics 33(22):3658\u20133660. https:\/\/doi.org\/10.1093\/bioinformatics\/btx491","journal-title":"Bioinformatics"},{"issue":"9","key":"11072_CR54","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"issue":"16","key":"11072_CR55","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26(16):1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"issue":"10","key":"11072_CR56","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17(10):6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"key":"11072_CR57","doi-asserted-by":"publisher","unstructured":"Miller BR 3rd, McGee TD Jr, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2017) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8(9):3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","DOI":"10.1021\/ct300418h"},{"issue":"6","key":"11072_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026708","volume":"7","author":"RL Bennett","year":"2017","unstructured":"Bennett RL, Swaroop A, Troche C, Licht JD (2017) The role of nuclear receptor-binding SET domain family histone lysine methyltransferases in cancer. Cold Spring Harb Perspect Med 7(6):a026708. https:\/\/doi.org\/10.1101\/cshperspect.a026708","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"11072_CR59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH et al (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19(8):649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"key":"11072_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/636514","volume":"2014","author":"Z Xie","year":"2014","unstructured":"Xie Z, Chng WJ (2014) MMSET: role and therapeutic opportunities in multiple myeloma. Biomed Res Int 2014:636514. https:\/\/doi.org\/10.1155\/2014\/636514","journal-title":"Biomed Res Int"},{"issue":"4","key":"11072_CR61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF00228148","volume":"8","author":"RA Laskowski","year":"1996","unstructured":"Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477\u2013486. https:\/\/doi.org\/10.1007\/BF00228148","journal-title":"J Biomol NMR"},{"issue":"5016","key":"11072_CR62","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.1853201","volume":"253","author":"JU Bowie","year":"1991","unstructured":"Bowie JU, L\u00fcthy R, Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253(5016):164\u2013170. https:\/\/doi.org\/10.1126\/science.1853201","journal-title":"Science"},{"key":"11072_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115232","volume":"250","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zha X (2023) Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: an update and perspectives. Eur J Med Chem 250:115232. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115232","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11072-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11072-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11072-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:03:55Z","timestamp":1758600235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11072-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["11072"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11072-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}